search
Back to results

Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Patients (Lambda_MIpil)

Primary Purpose

Stroke

Status
Recruiting
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Group of strength training
Group of physiotherapy not focus on strength training
Sponsored by
Institution de Lavigny
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring lower limb, robotic device, strength training, subacute, rehabilitation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Acquired Brain Injury of vascular, traumatic, infectious or tumoral origin in the subacute phase
  • Walking ability ≤ Functional Ambulatory Category level 4 (1-6)
  • Paresis of the lower limb: strength <57/100 on the Motricity Index
  • Cognitive and memory functions allowing the patient to follow treatment instructions and give informed consent

Exclusion Criteria:

  • Significant heart problem
  • Venous thrombosis less than 6 months
  • Musculoskeletal impairment not compatible with movement
  • Degenerative neurological disease
  • Oxygen-dependent
  • Blood pressure not stabilized

Sites / Locations

  • Institution de LavignyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

intervention group

control group

Arm Description

group focus on lower limb strength training with a seated robotic device

physiotherapy group as usual, not focused on strength training

Outcomes

Primary Outcome Measures

change from study inclusion to end of intervention at 5 weeks in strength of knee extensor's
measure with a manuel dynamometer, in newton

Secondary Outcome Measures

change from study inclusion to end of intervention at 5 weeks in Motricity index legs
clinical manuel strength test, seating on a chair. From 0 to 33, 33 is normal strength.
change from study inclusion to end of intervention at 5 weeks in timed up and go
Mobility test: standing from a chair, walking 3 meters, turn around, returning and seat. in seconds
change from study inclusion to end of intervention at 5 weeks in 10 meters walk test
measure of mean gait speed on 10 meters, at comfortable and maximum gait speed. In meters/second.
change from study inclusion to end of intervention at 5 weeks in Ashworth Scale (spasticity)
measure of the resistance of a muscle to passive stretch according to REsistance to PASsive movement protocol. From 0 to 4, 4 is high spasticity.

Full Information

First Posted
August 12, 2021
Last Updated
July 12, 2022
Sponsor
Institution de Lavigny
search

1. Study Identification

Unique Protocol Identification Number
NCT05020171
Brief Title
Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Patients
Acronym
Lambda_MIpil
Official Title
Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Subacute Acquired Brain Injury Patients: a Pilot Study.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 20, 2021 (Actual)
Primary Completion Date
October 31, 2022 (Anticipated)
Study Completion Date
December 30, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institution de Lavigny

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The loss of lower limb strength that occurs after an Acquired Brain Injury (ABI) limits the patient's autonomy in participating in activities of daily living, including gait performance. In the sub-acute phase, it is difficult to implement a strengthening program, as weakness prevents exercise being performed with the recommended parameters. This limit can be exceeded by using specific robotic devices, which allow the effort provided to be adapted according to the patient's capacities. In addition, motivation can be improved by the use of feedback or incentive games. The aim of this pilot study is to obtain data on the effect of lower limb strength training with a seated robotic device in subacute ABI patients for a future larger randomised study. In addition, it aims to evaluate the recruitment rate, applicability, resources for implementation and patient tolerance to the training program.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
lower limb, robotic device, strength training, subacute, rehabilitation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
intervention group
Arm Type
Experimental
Arm Description
group focus on lower limb strength training with a seated robotic device
Arm Title
control group
Arm Type
Active Comparator
Arm Description
physiotherapy group as usual, not focused on strength training
Intervention Type
Device
Intervention Name(s)
Group of strength training
Intervention Description
2x a week during 5 weeks, strengthening of weak muscles with the intensity recommended in the literature, i.e. 3-4x15 repetition at an intensity of 50 to 80% of the maximum force combined with serious games to stimulate patient involvement in strength training
Intervention Type
Other
Intervention Name(s)
Group of physiotherapy not focus on strength training
Intervention Description
2x a week during 5 weeks, active physical therapy treatment based on movement
Primary Outcome Measure Information:
Title
change from study inclusion to end of intervention at 5 weeks in strength of knee extensor's
Description
measure with a manuel dynamometer, in newton
Time Frame
Study inclusion to end of intervention at 5 weeks
Secondary Outcome Measure Information:
Title
change from study inclusion to end of intervention at 5 weeks in Motricity index legs
Description
clinical manuel strength test, seating on a chair. From 0 to 33, 33 is normal strength.
Time Frame
Study inclusion to end of intervention at 5 weeks
Title
change from study inclusion to end of intervention at 5 weeks in timed up and go
Description
Mobility test: standing from a chair, walking 3 meters, turn around, returning and seat. in seconds
Time Frame
Study inclusion to end of intervention at 5 weeks
Title
change from study inclusion to end of intervention at 5 weeks in 10 meters walk test
Description
measure of mean gait speed on 10 meters, at comfortable and maximum gait speed. In meters/second.
Time Frame
Study inclusion to end of intervention at 5 weeks
Title
change from study inclusion to end of intervention at 5 weeks in Ashworth Scale (spasticity)
Description
measure of the resistance of a muscle to passive stretch according to REsistance to PASsive movement protocol. From 0 to 4, 4 is high spasticity.
Time Frame
Study inclusion to end of intervention at 5 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Acquired Brain Injury of vascular, traumatic, infectious or tumoral origin in the subacute phase Walking ability ≤ Functional Ambulatory Category level 4 (1-6) Paresis of the lower limb: strength <57/100 on the Motricity Index Cognitive and memory functions allowing the patient to follow treatment instructions and give informed consent Exclusion Criteria: Significant heart problem Venous thrombosis less than 6 months Musculoskeletal impairment not compatible with movement Degenerative neurological disease Oxygen-dependent Blood pressure not stabilized
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Claude Pichonnaz, PhD
Phone
+41 21 316 81 26
Email
claude.pichonnaz@hesav.ch
First Name & Middle Initial & Last Name or Official Title & Degree
Nicolas Perret
Phone
+41 21 316 81 37
Email
nicolas.perret@hesav.ch
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Claude Pichonnaz, PhD
Organizational Affiliation
Haute Ecole de Santé Vaud
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institution de Lavigny
City
Lavigny
State/Province
Vaud
ZIP/Postal Code
1175
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pierre-André Rapin, PhD
Email
pierre-andre.rapin@ilavigny.ch

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Patients

We'll reach out to this number within 24 hrs